# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-029433
Filing Date
2022-08-12
Accepted
2022-08-12 16:15:54
Documents
3
Period of Report
2022-09-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20004814x4_def14a.htm | DEF 14A | 759594
2 |  | ny20004814x4-pc_1.jpg | GRAPHIC | 630705
3 |  | ny20004814x4-pc_2.jpg | GRAPHIC | 381703
| Complete submission text file | 0001140361-22-029433.txt |  | 2154510

Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-11460 | Film No.: 221160270
SIC: 2834 Pharmaceutical Preparations